Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

NCT00043316 is registered in ClinicalTrials.gov with InterMune as lead sponsor.

NCT NCT00043316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00043316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
Lead sponsor
InterMune
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2001
Completion date
October 31, 2002
Enrollment
66 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis